Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jul 2026 and Aug 2026.
- Largest single sale: $1.8M (14,661 shares) of Incyte on Jul 31, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Incyte (INCY) | EVP & Chief Scientific Officer | Aug 5, 2025 | Aug 7, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 5, 2026, Incyte: sold 2,207 shares for $274K, under a disclosed plan; 2,207 shares acquired by exercising options. 1 filing: 1
- Aug 3, 2026, Incyte: sold 6,055 shares for $729K, under a disclosed plan; 6,055 shares acquired by exercising options. 1 filing: 1
- Jul 31, 2026, Incyte: sold 41,899 shares for $5.0M, under a disclosed plan; 39,712 shares acquired by exercising options. 1 filing: 1
- Jul 16, 2026, Incyte: 5,916 shares granted. 1 filing: 1
- Jul 15, 2026, Incyte: 1,512 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.